16-Dec-2021 - 16-Dec-2021
Nordic Nanovector to Present at DNB's 12th Nordic Healthcare Conference
-
Contact:
- Organiser: Nordic Nanovector
- Name: Nordic Nanovector
- Email: help@pharmiweb.com
Nordic Nanovector to Present at DNB's 12th Nordic Healthcare Conference
Oslo, Norway, 8 December 2021
Nordic Nanovector ASA (OSE: NANOV), clinical-stage biotech company focused on CD37-targeted therapies for haematological cancers and immune diseases, announces that its CEO, Erik Skullerud will present a corporate overview via live webcast at DNB's 12th Nordic Healthcare Conference on 16 December 2021. The presentation will take place from 10:15-10:35 CET.
The presentation will be available at the same time at www.nordicnanovector.com in the section: Investors & Media/Reports and Presentation/Presentations.
For further information, please contact:
IR enquiries
Malene Brondberg, CFO
Cell: +44 7561 431 762
Email: ir@nordicnanovector.com
